Keywords: resovist, recommended, approval, japan, nihon, schering, magnetic

Resovist recommended for approval in Japan

Article | 22 July 2002

Nihon Schering's magnetic resonance imaging contrast medium, Resovist(ferucarbotran), has been recommended for approval in Japan for the diagnosis of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Brevibloc

Esmolol

Carvedilol

Coreg

Go to drug listing